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Edited by Shou-Wei DingAbstract MicroRNAs (miRNA) are short RNA molecules reg-
ulating the expression of speciﬁc mRNAs. We investigated the
expression pattern and potential targets of mouse miR-140 and
found that miR-140 is speciﬁcally expressed in cartilage tissues
of mouse embryos during both long and ﬂat bone development.
MiR-140 expression was detected in the limbs of E11.5 embryos
in the primorida of future bones both in the fore and hindlimb
and across autopod, zeugopod and stylopod. All digits of E14.5
fore- and hindlimbs showed accumulation of miR-140, except
the ﬁrst digit of the hindlimb. MiR-140 expression was also de-
tected in the cartilagenous base of E17.5 skulls and in the ster-
num, the proximal rib heads and the developing vertebral
column of E15.5 embryos. A potential target of miR-140, histone
deacetylase 4, was validated experimentally and the possible role
of miR-140 in long bone development is discussed.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The formation and longitudinal growth of much of the ver-
tebrate skeleton relies critically on the process of endochondral
ossiﬁcation. This is coordinated by resident chondrocytes
which lay down a cartilagenous template rich in particular
extracellular matrix (ECM) molecules and undergo a program
of proliferation, maturation and hypertrophy. Vascular inva-
sion, remodelling of ECM and delivery of osteoprogenitors
to this template results in the formation of bone. Chondrocytes
in the articular cartilage are constrained from completing this
program, allowing the maintenance of a low friction load-bear-
ing cartilageous surface that facilitates joint movement [1].
Identifying the factors that regulate these intricate processes
will help our understanding of the development and diseases
of the skeleton alike.
Histone deacetylases (HDACs) are generally transcriptional
co-repressors that modulate cell growth, diﬀerentiation and
apoptosis [2]. HDAC4-null mice display a skeletal phenotype,*Corresponding author. Fax: +44 1603 592250.
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mature ossiﬁcation [3]. HDAC4 is expressed in prehypertro-
phic chondrocytes and appears to regulate hypertrophy by
inhibiting the action of Runx2, a key transcription factor re-
quired for both chondrocyte hypertrophy and osteoblast dif-
ferentiation [1]. This establishes HDAC4 as a critical
regulator of chondrocyte hypertrophy and skeletogenesis.
In addition to transcription factors and histone deacetylases,
microRNAs (miRNAs) have emerged as a new class of gene
expression regulators. MiRNAs are 20–24 nucleotide non-cod-
ing RNA molecules that post-transcriptionally regulate gene
expression. They are generated from precursor RNA molecules
with hairpin structure – the enzyme Dicer cleaves the partially
double-stranded stem and releases the mature miRNA [4]. One
of the mature miRNA strands forms an eﬀector ribonucleopro-
tein complex termed RISC (RNA induced silencing complex)
which guides the miRNAs to speciﬁc mRNAs [5]. RISC either
cleaves or blocks translation of the target mRNA, depending
on the degree of sequence complementarity. The majority of
miRNA targets in animals are not cleaved but translationally
suppressed due to the mismatches between miRNAs and target
sites. The number of experimentally validated miRNA targets
is growing but is still low [6] due to the lack of a generally appli-
cable miRNA target identiﬁcation protocol. Several computer
programmes are available to predict targets for miRNAs [7]
(http://microrna.sanger.ac.uk/targets/v2/) but these predictions
have to be validated experimentally. This is a laborious task,
however, as hundreds of targets are usually predicted for each
miRNA. One way of reﬁning the list of putative targets and
identifying those worth validating experimentally, is to com-
pare the expression patterns of miRNAs and predicted targets.
Initially it was not possible to establish miRNA expression pat-
terns by in situ hybridization due to their small size. Recently,
however, oligonucleotides containing locked nucleic acid
(LNA) nucleotides have emerged as a powerful tool for obtain-
ing meaningful signals from hybridization of short miRNA-
encoding sequences to their speciﬁc target mRNAs, even in
whole mount in situ hybridization reactions (WMISH) [8,9].
Wienholds et al. [8] have demonstrated the tissue-speciﬁc
expression pattern of about 120 miRNAs in zebraﬁsh embryos.
One of these, miR-140, was found to be expressed only in
cartilagenous tissue. Based on other miRNAs’ conserved
expression pattern in diﬀerent vertebrates it was expected that
miR-140 would also show cartilage-speciﬁc expression inmouse
embryos. However, the precise expression pattern in mouse was
not entirely predictable, as there are several morphological dif-
ferences between zebraﬁsh and mouse embryos. In addition,blished by Elsevier B.V. All rights reserved.
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mouse embryo at all.
Here we describe the expression pattern of miR-140 in the
developing mouse embryo by WMISH and in situ hybridiza-
tion on dissected tissues. MiR-140 was ﬁrst detected at 11.5
days post-conception (E11.5) and throughout subsequent
stages of development, it was detected speciﬁcally in cartilag-
enous tissues in the developing limbs, ribs, vertebrate, sternum
and the skull. We also veriﬁed HDAC4 as a miR-140 target
using the luciferase reporter assay and by western blot analysis
after miR-140 transfection. Our results point to an important
role by miR-140 in the formation and/or maintenance of carti-
lage involving HDAC4.2. Results and discussion
2.1. Expression pattern of miR-140 in mouse embryo
We used a digoxigenin-labelled LNA oligonucleotide
probe, antisense to miR-140 in WMISH experiments to study
the spatial expression pattern of miR-140 in the developing
mouse embryo. In each experiment, an antisense probe for
the plant-speciﬁc miR-171 was used as a negative control.
In all the studied tissue types, miR-140 showed a cartilage-
speciﬁc expression pattern. Ten and a half day old embryos
(E10.5) did not show miR-140 expression (Fig. 1A), a ﬁnding
that is in agreement with a recent report by Kloosterman
et al. [9]. The most likely explanation is that cartilage has
not formed at E10.5. We therefore analysed older embryos
and found that miR-140 is expressed in the developing limbs
at E11.5, as shown in Fig. 1B and C. This expression high-
lights distinct elements within the autopod and zeugopod
of both the fore and hindlimb. In some experiments, we al-
lowed the colour reaction to proceed for a longer period
and this enhanced the limb-speciﬁc signal within the auto-
pod, zeugopod and stylopod (Fig. 1E and F). Our negative
control, miR-171, did not yield any signal in E11.5 embryo
(Fig. 1D and G).
Next we examined miR-140 expression within the develop-
ing digits of E14.5 embryos. To allow better penetration of
the probe we used dissected limbs. miR-140 expression was
clearly visible in the developing phalangeal elements but was
absent from the intervening joints (Fig. 1H and I). The signal
was more intense in the forelimb than hindlimb and altogether
absent from hindlimb digit I, possibly reﬂecting the fact that
hindlimb development lags behind that of forelimb.
To address whether miR-140 is a limb speciﬁc or cartilage
speciﬁc marker, we examined the expression of miR140 in
non-limb cartilagenous elements. Whole E15.5 rib cages and
E17.5 skulls were dissected and were subjected to WMISH.
We found that miR-140 is expressed in the sternal anlage, ver-
tebral bodies and proximal heads of ribs (Fig. 1N and O). In
the E17.5 skull, miR140 was expressed in the cartilagenous
base of the skull (Fig. 1J), a tissue that resides just medial to
developing calvarial bones and in which we had previously de-
tected Fgf18 [10] (Fig. 1K). Use of miR 171 probe did not yield
a signal in any of these tissues (Fig. 1L and M).
Taking together, these ﬁndings show that miR-140 is ex-
pressed speciﬁcally in cartilage tissues during mouse embryonic
development, as reported in zebraﬁsh embryos [8]. Our results
also demonstrate the feasibility of studying miRNA expression
patterns in dissected/individual organs of E12.5 and olderembryos, otherwise not aﬀorded due to poor penetration of
probes into whole embryos.
2.2. HDAC4 is a target of miR-140
After analyzing the expression pattern of miR-140, com-
puter-based predictions from TargetscanS [7] were searched
for potential miR-140 targets associated with chondrogenesis.
Out of the 138 predicted targets, HDAC4 was selected for
validation by luciferase reporter assay because it is a known
regulator of chondrocyte hypertrophy during skeletogenesis
[3]. The miR-140 seed sequence (5 0-GTGGTTT-3 0, nucleo-
tides 2–8) matches to nucleotides 5000–5006 of HDAC4
(NM_006037) with a score of 0.37 from TargetscanS [7]. To
validate HDAC4 as a target, wild-type (WT) and mutant
(MUT) 3 0 UTRs were cloned into a modiﬁed pGL3 control
vector. WT sequence was prepared by inserting an 800 bp re-
gion of the HDAC4 3 0 UTR into the luciferase 3 0 UTR of
the modiﬁed pGL3 control vector. For the mutant construct,
the target site was rendered insensitive to miR-140 by introduc-
ing three point mutations (Fig. 2A). For the assay, the cellular
level of miR-140 was artiﬁcially increased by using a siRNA
that mimicked miR-140 (siRNA-140). If miR-140 targeted
the HDAC4 3 0 UTR then a reduction in light signal would
be observed in cells co-transfected with WT construct and siR-
NA-140, compared to WT construct without siRNA-140 and
to mutant constructs co-transfected with siRNA-140. We
found that reporter activity did not diﬀer between WT and mu-
tant constructs in the absence of siRNA-140 (Fig. 2A). How-
ever, upon co-transfection of WT construct with siRNA-140,
a marked decrease in reporter activity (51%) was observed
relative to non-siRNA treated cells (Fig. 2A). Reduction of
reporter activity was signiﬁcantly less when siRNA-140 was
co-transfected with the mutant target or when WT or mutant
targets were co-transfected with scrambled siRNA (Fig. 2A).
Co-transfection of a non-speciﬁc siRNA, reverse complemen-
tary to miRNA-449, resulted in an upregulation of reporter
activity relative to WT sequences (data not shown). This indi-
cates that miR-140 interferes with translation of HDAC4
mRNA via direct binding to the 3 0 UTR.
We also investigated the eﬀect of the miR-140 mimicking
siRNA on HDAC4 accumulation in a more natural condition.
3T3 mouse ﬁbroblast cells express HDAC4 at a relatively high
level and are amenable to transfection. We analysed the level
of HDAC4 by Western blot after transfecting 3T3 cells with
siRNA-140 or a non-speciﬁc siRNA. Fig. 2B shows that
the control siRNA did not aﬀect the level of HDAC4 but
siRNA-140 signiﬁcantly downregulated the accumulation of
HDAC4 protein, conﬁrming that it is indeed a target of
miR-140, at least in vitro.
HDAC4 was recently shown to be a target of miR-1 during
skeletal muscle development [11], although there is no relation-
ship between mir-1 and mir-140. HDAC4 is a transcriptional
repressor of muscle diﬀerentiation, therefore miR-1 promotes
diﬀerentiation by suppressing HDAC4 during muscle develop-
ment. We propose that the function of miR-140 in cartilage tis-
sues is similar to miR-1 function in muscle: it may promote
diﬀerentiation by potentially suppressing HDAC4 that is a
known co-repressor of Runx2 [3] that is a transcription factor
essential for chondrocyte hypertrophy and osteoblast diﬀeren-
tiation [1]. Our results also demonstrate that the same gene can
be regulated by diﬀerent tissue speciﬁc miRNAs during diﬀer-
ent developmental processes.
Fig. 1. Cartilage-speciﬁc expression of miR-140 during mouse embryonic development. Figure shows the expression pattern of miR-140 in whole
E11.5 embryos (B, C, E, F) or dissected tissues of older embryos (H–K, N and O). No signal is detected using a control plant-speciﬁc miRNA,
miR171 (D, G, L and M). MiR-140 is not detected at E10.5 (A). B, C, E and F show miR-140 expression in E11.5 limbs; miR-140 labels the
primorida of future bones both in the fore and hindlimb, and across autopod, zeugopod and stylopod. H and I, all digits of E14.5 fore- (H) and hind
limbs (I), except the ﬁrst digit of the hind limb (arrows) show strong expression of miR-140. J and K, dorsal and ventral views of dissected E17.5
skulls, show miR-140 expression in the cartilagenous base of the skull (arrows in J). N, posterior view of the rib cage, showing that miR-140 is
expressed in the sternum. O, ventral view of the vertebral column and ribs, showing speciﬁc miR-140 expression in the proximal rib heads (arrow) as
well as the developing vertebral column.
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3.1. Whole mount in situ hybridization
In situ hybridizationwas carried out as described byWheeler et al. [12]
using the following Proteinase K treatment times for diﬀerent develop-
mental stages: E10.5 (30 min); E11.5 (40 min); E14.5 limbs, E15.5 ribs,
E17.5 skull (all 45 min). To further enhance probe penetrations, excess
skin and muscles were removed after proteinase K treatment.3.2. DNA constructs
pGL3 control vector (Promega) was modiﬁed by ﬁrst deleting the
region between SacI and BglII upstream of the SV40 promoter. A mul-
tiple cloning site (MCS) (5 0-TCTAGAGAGCTCAGATCTCCCG-
GGCTCGAGGCTAGCCTCTAGA-3 0) was then inserted into the
XbaI site downstream of the luciferase stop codon. For the wild-type
(WT) construct, the ﬁrst 800 bp of the HDAC4 3 0 UTR were PCR
ampliﬁed from human genomic DNA and cloned into pGemT-Easy
Fig. 2. HDAC4 is targeted by miR-140. (A) Downregulation of
luciferase activity by a miR-140 mimicking siRNA (siRNA-140). The
wild-type (WT) and a mutated (MUT) 3 0 UTR region of HDAC4 are
shown together with the mir-140 sequence. The predicted target site is
shown in bold and the mutated nucleotides are underlined. The wild-
type and mutated miR-140 target sites were cloned downstream of the
luciferase gene and plasmids were transfected with or without siRNAs
(siRNA-140 or scrambled siRNA; siRNA-scr) into 3T3 cells. Relative
reporter activity is shown as mean ± S.E.M. from six experiments
performed in triplicate using two independent plasmid preparations.
***P < 0.01 (students t test). (B) Downregulation of HDAC4 expres-
sion by siRNA-140. 3T3 cells were transfected with siRNA-140,
siRNA-449 as a negative control or with transfection reagent only
(mock). Western blot analysis of 2 lg of total protein showed that
siRNA-140 speciﬁcally downregulated HDAC4. Equal loading is
shown by the accumulation of B-actin. The two lanes from each set
represent two independent samples.
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incorporate SacI and NheI restriction sites to the 5 0 and 3 0 end, respec-
tively, and inserted into the MCS of pGL3. For the mutant pGL3 con-
struct, the predicted target site from TargetscanS [7] was replaced with a
HindIII site introducing three point mutations.
3.3. Transfections and luciferase assay
Mouse 3T3 cells were cultured in Dulbecco’s modiﬁed Eagle med-
ium (DMEM) containing 2 mM L-glutamine and 10% foetal bovine
serum (FBS) (Gibco, Invitrogen). 3T3 cells (3 · 104 cells/well) were
transfected with Lipofectamine 2000 (Invitrogen) with either WT or
mutant constructs (200 ng), with and without siRNA-140 (30 nM)
(Dharmacon). siRNA-140 contained 5 0-CAGUGGUUUUACC-
CUAUGGUAG-3 0 and 5 0-ACCAUAGGGUAAAACCACUGAG-3 0
oligonucleotides.
As a positive control, the modiﬁed pGL3 control vector was used
without a 3 0 UTR insert. Lipofectamine only treated cells served as
negative controls. Transfections were carried out six times in triplicate
using two independent plasmid preparations. Luciferase activity wasmeasured 24 h later using a multilabel counter (Victor2, Perkin–Elmer,
MA). Relative reporter activity for siRNA-140 treated cells was ob-
tained by normalization to non-siRNA-140 treated WT or mutant con-
structs, respectively.
3.4. Western blots
3T3 cells (3 · 104 cells/well) were transfected with siRNA-140 or siR-
NA-449 (Dharmacon) using Dharmafect (Dharmacon), at ﬁnal con-
centrations of 10 nM or 100 nM. Dharmafect-only treated cells were
used as negative controls. siRNA-449 contained 5 0-UGGCAGU-
GUAUUGUUAGCUGGU-3 0 and 5 0-CAGCUAACAAUACACUG-
CCAGU-3 0 oligonucleotides. Whole cell lysates were extracted 48 h
later and Western blotting was performed using standard procedures.
HDAC4 and B-actin antibodies from rabbit and horseradish-peroxi-
dase conjugated anti-rabbit antibody were purchased from Abcam
(Cambridge, UK).
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